A detailed history of Employees Retirement System Of Texas transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Employees Retirement System Of Texas holds 43,769 shares of DNLI stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,769
Previous 43,769 -0.0%
Holding current value
$1.06 Million
Previous $1.02 Million 25.49%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$15.83 - $23.35 $354,497 - $522,899
22,394 Added 104.77%
43,769 $898,000
Q4 2023

Feb 15, 2024

BUY
$16.2 - $23.18 $346,275 - $495,472
21,375 New
21,375 $459,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.25B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.